* USANA Health Sciences Inc USNA.N USNA.K is expected
to show
a fall in quarterly revenue when it reports results on February
8.
* The Salt Lake City Utah-based company is expected to
report a
12.4% decrease in revenue to $271.933 million from $310.52
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for USANA Health
Sciences Inc
is for earnings of $1.28 per share. For the same quarter last
year, the company reported earnings of $1.87 per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for USANA
Health
Sciences Inc is $100, about 7.7% above its last closing price
of $92.32.
This summary was machine generated February 4 at 22:42 GMT. All
figures in US dollars unless otherwise stated